PIA
ABBV icon

Perennial Investment Advisors’s AbbVie ABBV Stock Holding History

Perennial Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
6,161
+1,897
+44% +$408K 0.1% 167
2026
Q1 		$927K Sell
4,264
-64
-1% -$14.2K 0.07% 199
2025
Q4 		$989K Buy
4,328
+127
+3% +$28.9K 0.08% 190
2025
Q3 		$973K Buy
4,201
+61
+1% +$12.4K 0.08% 183
2025
Q2 		$768K Buy
4,140
+116
+3% +$21.6K 0.07% 202
2025
Q1 		$843K Buy
4,024
+142
+4% +$27.6K 0.09% 179
2024
Q4 		$690K Buy
3,882
+530
+16% +$97.4K 0.08% 187
2024
Q3 		$662K Buy
3,352
+2
+0.1% +$373 0.09% 178
2024
Q2 		$574K Sell
3,350
-267
-7% -$44.2K 0.08% 181
2024
Q1 		$659K Buy
3,617
+181
+5% +$31.2K 0.1% 163
2023
Q4 		$533K Sell
3,436
-382
-10% -$55.7K 0.09% 172
2023
Q3 		$569K Buy
3,818
+364
+11% +$53.4K 0.1% 159
2023
Q2 		$465K Buy
3,454
+37
+1% +$5.43K 0.08% 187
2023
Q1 		$545K Buy
3,417
+56
+2% +$8.56K 0.1% 163
2022
Q4 		$543K Sell
3,361
-7
-0.2% -$1.07K 0.22% 95
2022
Q3 		$452K Buy
3,368
+322
+11% +$46.2K 0.21% 91
2022
Q2 		$468K Sell
3,046
-70
-2% -$10.7K 0.18% 102
2022
Q1 		$507K Sell
3,116
-91
-3% -$13.2K 0.16% 110
2021
Q4 		$434K Sell
3,207
-85
-3% -$10K 0.14% 138
2021
Q3 		$357K Sell
3,292
-28
-0.8% -$3.2K 0.13% 147
2021
Q2 		$374K Sell
3,320
-226
-6% -$25.5K 0.14% 131
2021
Q1 		$384K Sell
3,546
-249
-7% -$26.6K 0.15% 121
2020
Q4 		$407K Buy
3,795
+656
+21% +$63K 0.17% 102
2020
Q3 		$275K Buy
3,139
+78
+3% +$7.34K 0.14% 117
2020
Q2 		$301K Buy
3,061
+70
+2% +$6.16K 0.2% 97
2020
Q1 		$228K Buy
2,991
+165
+6% +$14.1K 0.2% 98
2019
Q4 		$251K Buy
+2,826
New +$235K 0.2% 109

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perennial Investment Advisors's ABBV Position: Q2 2026 in Review

Perennial Investment Advisors increased its AbbVie (ABBV) stake by 44% in Q2 2026, buying an estimated $408K and bringing the position to 6,161 shares worth $1.55M. The position accounts for 0.1% of the portfolio, ranked #167.

Perennial Investment Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Perennial Investment Advisors held 6,161 shares of AbbVie worth $1.55M as of Q2 2026.
  • Perennial Investment Advisors bought 1,897 AbbVie shares in Q2 2026, an estimated $408K.
  • AbbVie made up 0.1% of Perennial Investment Advisors's portfolio in Q2 2026, its #167 holding.
  • Perennial Investment Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Perennial Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.